Treated with levothyroxine | Untreated | Controls | p-value | ||
---|---|---|---|---|---|
Before SpA | Newly after SpA | ||||
n | 45 | 28 | 38 | 147 | |
Age (years) | 33 | 34 | 32 | 33 | 0.314 |
BMI | 22.29 | 21.94 | 23.42 | 21.34 | 0.698 |
Family history of thyroid disease | 19 (42%) | 10 (36%) | 14 (37%) | 37 (25%) | 0.118 |
Autoimmune pattern in TUS | 10 (22%) | 23 (82%) | 30 (73%) | 0 (0%) | <0.001 |
FT4 (pmol/l) | 14.75 (11.70-22.20) | 14.20 (11.30-20.60) | 13.80 (11.00-17.50) | 14.40 (11.10-20.20) | 0.278 |
TSH (mIU/l) | 1.84 (0.51-7.32) | 2.26 (0.89-8.88) | 1.91 (0.30-4.52) | 1.54 (0.58-3.94) | 0.002 |
TPOAb (kIU/l) | 68.00 (15.00-4480.00) | 118.00 (33.00-2820.00) | 42.50 (22.00-1805.00) | 41.00 (0.00-163.00) | <0.001 |
Subclinical hypothyroidism | - | 8 (28%) | 13 (34%) | - | 0.827 |
Euthyroid AITD | - | 20 (71%) | 25 (66%) | - | 0.827 |